Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Celiac disease requires more than just a gluten-free diet for effective management.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Alitretinoin may help treat alopecia areata.

Blocking CRF-R1 can reduce alcohol intake in stressed mice.

Ca²⁺-mediated protein citrullination controls cell growth in the CNS and may help treat brain tumors.

Telocytes in the scalp may help with skin regeneration and maintenance.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

TEDAR is crucial for skin cell differentiation and barrier formation.

Autoimmune diseases need combined therapy of tolerance induction and immunosuppression.

Next-generation Treg therapies could help achieve lasting immune tolerance in type 1 diabetes.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

SHISA6 helps maintain certain stem cells in mouse testes by blocking signals that would otherwise cause them to differentiate.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Cardiomyocyte-derived media can inhibit lung cancer cell growth and movement.

ILC1-like cells may contribute to hair loss in alopecia areata.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

Blocking CXCL12 can reverse hair loss and fibrosis in androgenetic alopecia.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

High doses of cyclosporine A increase testosterone conversion, possibly boosting hair growth.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

RXR-alpha is strongly expressed in both normal and psoriatic skin and may help in skin cell differentiation and hair growth.

Lack of functional CYLD in mice leads to early aging and cancer.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

HPV8 causes hair follicle stem cells to grow, leading to skin lesions.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.